Literature DB >> 8547598

Function and expression of the Bcl-x gene in the developing and adult nervous system.

H Frankowski1, M Missotten, P A Fernandez, I Martinou, P Michel, R Sadoul, J C Martinou.   

Abstract

We have shown that overexpression of Bcl-x can rescue sympathetic neurones from nerve growth factor deprivation in vitro. We have also examined the distribution and expression of Bcl-x mRNA in the developing and adult nervous system using Northern blot and in situ hybridization. Bcl-x mRNA is widespread during development of the nervous system. In embryonic spinal cord, mRNA levels increase at the beginning of the naturally occurring cell death period, suggesting that Bcl-x may be involved in the selection of neurones during this period. In the brain, Bcl-x expression increases after birth to reach a high level in the adult brain. Neurones from the cortex, olfactory bulb, and Purkinje cells are among those expressing the highest levels of Bcl-x mRNA. The widespread expression of Bcl-x during development and in adult brain suggests of a role for Bcl-x beyond simply protecting neurones from developmental cell death.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8547598     DOI: 10.1097/00001756-199510020-00023

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  17 in total

1.  Modulation of synaptic transmission by the BCL-2 family protein BCL-xL.

Authors:  Elizabeth A Jonas; Daniel Hoit; John A Hickman; Teresa A Brandt; Brian M Polster; Yihru Fannjiang; Erin McCarthy; Marlena K Montanez; J Marie Hardwick; Leonard K Kaczmarek
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

2.  Expression of cellular oncogene Bcl-xL prevents coronavirus-induced cell death and converts acute infection to persistent infection in progenitor rat oligodendrocytes.

Authors:  Yin Liu; Xuming Zhang
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Bcl-xL protects adult septal cholinergic neurons from axotomized cell death.

Authors:  U Blömer; T Kafri; L Randolph-Moore; I M Verma; F H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 4.  Genetic control of programmed cell death during animal development.

Authors:  Barbara Conradt
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

5.  Effect of hypoxia on expression of apoptotic proteins in nuclear, mitochondrial and cytosolic fractions of the cerebral cortex of newborn piglets: the role of nuclear Ca++ -influx.

Authors:  Maria Delivoria-Papadopoulos; Qazi M Ashraf; Om P Mishra
Journal:  Neurochem Res       Date:  2008-02-21       Impact factor: 3.996

6.  Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons.

Authors:  D S Park; B Levine; G Ferrari; L A Greene
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

7.  Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells.

Authors:  Zhen Li; Scott R McKercher; Jiankun Cui; Zhiguo Nie; Walid Soussou; Amanda J Roberts; Tina Sallmen; Jeffrey H Lipton; Maria Talantova; Shu-ichi Okamoto; Stuart A Lipton
Journal:  J Neurosci       Date:  2008-06-25       Impact factor: 6.167

8.  Proapoptotic N-truncated BCL-xL protein activates endogenous mitochondrial channels in living synaptic terminals.

Authors:  Elizabeth A Jonas; John A Hickman; Mushtaque Chachar; Brian M Polster; Teresa A Brandt; Yihru Fannjiang; Iva Ivanovska; Gorka Basañez; Kathleen W Kinnally; Joshua Zimmerberg; J Marie Hardwick; Leonard K Kaczmarek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-01       Impact factor: 11.205

Review 9.  Cell death, Bcl-2, Bax, and the cerebellum.

Authors:  Michael W Vogel
Journal:  Cerebellum       Date:  2002-12       Impact factor: 3.847

Review 10.  Regulation of synaptic transmission by mitochondrial ion channels.

Authors:  Elizabeth Jonas
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.